Physiological response to superantigen-adsorbing hemoperfusion in toxin-concentration-controlled septic swine

被引:11
作者
Miwa, K
Fukuyama, M
Matsuno, N
Shimada, K
Ikeda, K
Ikeda, T
机构
[1] Toray Industries Ltd, New Frontiers Res Labs, Kanagawa 2488555, Japan
[2] Toray Industries Ltd, Special Mat Res Labs, Shiga, Japan
[3] Tokyo Med & Dent Univ, Dept Surg 5, Hachioji Med Ctr, Tokyo, Japan
[4] Tokyo Med & Dent Univ, Hachioji Med Ctr, Div Crit Care & Emergency Med, Tokyo, Japan
关键词
superantigen; sepsis; multiple organ dysfunctions; animal model; swine;
D O I
10.1159/000091851
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Background/Aims: Superantigens are suspected of being potent initiators of gram-positive sepsis, and new therapies for superantigen elimination are required. The effects of hemoadsorption with a superantigen-adsorbing device (SAAD) were evaluated in septic swine. Methods:Toxic shock syndrome toxin-1 (TSST-1) was infused, and blood concentration was maintained at the clinical level for 6 h. Endotoxin was then infused to induce lethal shock. All animals were hemoperfused with SAAD or a control column for 8 h and changes in pathological parameters and mortality were examined. Results: Animals perfused with SAAD had a highly significant (p < 0.01) survival advantage compared with control groups at 24 h after initiation of the TSST-1 infusion. SAAD also suppressed the increase in the arteriovenous shunt ratio and decrease of partial arterial oxygen pressure at 6 h after TSST-1 infusion initiation. Conclusion: We suggest that there is a potential application of SAAD in treating superantigen-induced respiratory dysfunction and sepsis.
引用
收藏
页码:319 / 326
页数:8
相关论文
共 19 条
[1]
Detection of circulating superantigens in an intensive care unit population [J].
Azuma, K ;
Koike, K ;
Kobayashi, T ;
Mochizuki, T ;
Mashiko, K ;
Yamamoto, Y .
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2004, 8 (05) :292-298
[2]
REPORT OF THE AMERICAN-EUROPEAN CONSENSUS CONFERENCE ON ARDS - DEFINITIONS, MECHANISMS, RELEVANT OUTCOMES AND CLINICAL-TRIAL COORDINATION [J].
BERNARD, GR ;
ARTIGAS, A ;
BRIGHAM, KL ;
CARLET, J ;
FALKE, K ;
HUDSON, L ;
LAMY, M ;
LEGALL, JR ;
MORRIS, A ;
SPRAGG, R ;
DHAINAUT, JF ;
MATTHAY, M ;
MANCEBO, J ;
MEYRICK, B ;
PAYEN, D ;
PERRET, C ;
FOWLER, AA ;
SCHALLER, MD ;
VANASBECK, BS ;
COCHIN, B ;
LANKEN, PN ;
LEEPER, KV ;
MARINI, J ;
MURRAY, JF ;
OPPENHEIMER, L ;
PESENTI, A ;
REID, L ;
RINALDO, J ;
VILLAR, J ;
Hyers, T ;
Knaus, W ;
Matthay, R ;
Pinsky, M ;
Bone, RC ;
Bosken, C ;
Johanson, WG ;
Lewandowski, K ;
Repine, J ;
Rodriguez-Roisin, R ;
Roussos, C .
INTENSIVE CARE MEDICINE, 1994, 20 (03) :225-232
[3]
Superantigen and endotoxin synergize in the induction of lethal shock [J].
Blank, C ;
Luz, A ;
Bendigs, S ;
Erdmann, A ;
Wagner, H ;
Heeg, K .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (04) :825-833
[5]
DEAZAVEDO JCS, 1989, REV INFECT DIS, V11, pS205
[6]
Application of a rat model of streptococcal shock to evaluate on-line hemoperfusion and removal of circulating superantigens [J].
Fenwick, P ;
Ryan, C ;
Sriskandan, S ;
Cohen, J .
CRITICAL CARE MEDICINE, 2003, 31 (01) :171-178
[7]
Mixed bacterial infection model of sepsis in rabbits and its application to evaluate superantigen-adsorbing device [J].
Fukuyama, M ;
Miwa, K ;
Shibayama, N ;
Ogura, S ;
Nishiyama, T ;
Maekawa, N .
BLOOD PURIFICATION, 2005, 23 (02) :119-127
[8]
Holtfreter S, 2005, ARCH IMMUNOL THER EX, V53, P13
[9]
PURIFICATION AND CHARACTERIZATION OF STAPHYLOCOCCUS-AUREUS-FRI-1169 AND 587 TOXIC SHOCK SYNDROME EXOTOXINS [J].
IGARASHI, H ;
FUJIKAWA, H ;
USAMI, H ;
KAWABATA, S ;
MORITA, T .
INFECTION AND IMMUNITY, 1984, 44 (01) :175-181
[10]
IGARASHI H, 1989, REV INFECT DIS, V11, pS210